Presentation, Management, and Outcomes of Cyst-Associated Pancreatic Cancer versus Classic Pancreatic Ductal Adenocarcinoma
CA-PC has a better prognosis than PDAC in early stages but not in advanced disease, offering important insights for therapeutic strategies.
Authors
- Matthew H. G. Katz (ORCID: https://orcid.org/0000-0003-3870-6968)
- Hop S. Tran Cao (ORCID: https://orcid.org/0000-0001-8612-8272)
- Jeffrey E. Lee (ORCID: https://orcid.org/0000-0001-6010-5590)
- Michael P. Kim (ORCID: https://orcid.org/0000-0002-8269-854X)
- Jessica Maxwell (ORCID: https://orcid.org/0000-0003-4913-6518)
- Timothy Eric Newhook (ORCID: https://orcid.org/0000-0001-6663-459X)
- Naruhiko Ikoma (ORCID: https://orcid.org/0000-0002-9825-9234)
- Rebecca A. Snyder (ORCID: https://orcid.org/0000-0002-4355-2185)
- Ching-Wei D. Tzeng
- Yi-Ju Chiang
- Belkacem Acidi
Institutions
- The University of Texas MD Anderson Cancer Center (US)
Publication Details
- Journal
- Pancreas
- Published
- 2025-12-12
- DOI
- https://doi.org/10.1097/mpa.0000000000002608
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00